Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H25ClN2O5 |
Molecular Weight | 408.876 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C1=C(COCCN)NC(C)=C(C1C2=C(Cl)C=CC=C2)C(=O)OC
InChI
InChIKey=HTIQEAQVCYTUBX-UHFFFAOYSA-N
InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3
Molecular Formula | C20H25ClN2O5 |
Molecular Weight | 408.876 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:13:23 UTC 2023
by
admin
on
Fri Dec 15 17:13:23 UTC 2023
|
Record UNII |
1J444QC288
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C10BX14
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DB05
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09XA53
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DB04
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C10BX07
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DB01
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09BB04
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC08CA01
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
NCI_THESAURUS |
C333
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
NDF-RT |
N0000175421
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C10BX03
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
LIVERTOX |
NBK548585
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09BB03
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C08GA02
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09BB07
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09BB07
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09XA53
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C10BX09
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09XA54
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C07FB13
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DX03
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09BX03
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DB04
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
NDF-RT |
N0000000069
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DB01
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DX01
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DB07
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DX06
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC08GA02
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DB07
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
12.3
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C10BX11
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DX03
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DB02
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DB06
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
NDF-RT |
N0000007556
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09BB04
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DB06
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C08CA01
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC10BX03
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09DB05
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09BX01
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-VATC |
QC09BB03
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DX01
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
||
|
WHO-ATC |
C09DB02
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2668
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
2162
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
2669
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
C61635
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
17767
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | RxNorm | ||
|
m1757
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID7022596
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
DB00381
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
100000085259
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
Amlodipine
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
1J444QC288
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
6981
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
183
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
D017311
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
SUB05467MIG
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
88150-42-9
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
1J444QC288
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
7079
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
5729
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
CHEMBL1491
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY | |||
|
AMLODIPINE
Created by
admin on Fri Dec 15 17:13:24 UTC 2023 , Edited by admin on Fri Dec 15 17:13:24 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
ENANTIOMER -> RACEMATE |
|
||
|
EXCRETED UNCHANGED->SUBSTANCE |
AMOUNT EXCRETED
PLASMA; URINE
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR | |||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
DEGRADENT -> PARENT | |||
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE INACTIVE -> PARENT | |||
|
METABOLITE INACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||